Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.8%

4 terminated out of 59 trials

Success Rate

91.5%

+5.0% vs benchmark

Late-Stage Pipeline

19%

11 trials in Phase 3/4

Results Transparency

21%

9 of 43 completed with results

Key Signals

9 with results91% success

Data Visualizations

Phase Distribution

40Total
Not Applicable (18)
P 1 (2)
P 2 (9)
P 3 (10)
P 4 (1)

Trial Status

Completed43
Unknown8
Terminated4
Recruiting2
Active Not Recruiting1
Not Yet Recruiting1

Trial Success Rate

91.5%

Benchmark: 86.5%

Based on 43 completed trials

Clinical Trials (59)

Showing 20 of 20 trials
NCT04084249Not ApplicableActive Not Recruiting

ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

NCT07222800Phase 3Recruiting

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

NCT07351071Not ApplicableRecruiting

Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

NCT07114406Phase 3Not Yet Recruiting

A Study to Evaluate Safety and Efficacy of PBK_M2502

NCT03037385Phase 1Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT02647866Phase 2Completed

Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis

NCT03559543Phase 2Completed

Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma

NCT04644315Phase 2Terminated

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

NCT05923918Phase 3Unknown

A Study to Evaluate Safety and Efficacy of PBK_M2101

NCT04263818Not ApplicableCompleted

Endoscopist and Endoscope Motions During Colonoscopy

NCT04080843Phase 2Completed

Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients

NCT02291445Phase 2Completed

Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study

NCT03949777Not ApplicableCompleted

Validation of Aer-O-Scope Colonoscope System Cecal Intubation

NCT04074577Not ApplicableCompletedPrimary

Computer Aided Detection, Tandem Colonoscopy Study

NCT04598880Phase 4UnknownPrimary

Comparison of 1 Liter PEG With Ascorbate and Sodium Picosulfate / Magnesium Citrate for High Quality Colon Cleansing

NCT01087528Not ApplicableCompletedPrimary

Evaluation of PillCam™ Colon 2 in Visualization of the Colon

NCT04216901UnknownPrimary

A Single Center Study on the Effectiveness and Safety of Polyp Classification With Artificial Intelligence

NCT04316273CompletedPrimary

Colonic Duplication; Two Cases Report and Review of Literature

NCT00101725Phase 2Completed

A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome

NCT04087824Not ApplicableUnknownPrimary

Deep Learning Algorithm for Recognition of Colonic Segments.

Scroll to load more

Research Network

Activity Timeline